About Synteract

Established in 1995 by two veterans of the pharmaceutical industry, Synteract
is a privately held, full-service contract research organization (CRO),
dedicated to meeting the clinical research, technology, and
safety needs of biotechnology, medical device, and
pharmaceutical companies. Our mission is to
provide high quality yet personal service, working
closely with drug and device sponsors as though
we were a department within your company.
Headquartered in Carlsbad, California, we provide
expertise in a wide range of therapeutic areas in clinical trials,
including a strong emphasis in oncology, central nervous system (CNS),
cardiovascular disease, and ophthalmology.

Responsive and Flexible Track Record

With a successful track record of more than 14 years of clinical trial development and management with biotech and emerging companies, Synteract has earned a reputation as a responsive company, understanding the unique challenges inherent in performing clinical trials. Our full-service capabilities allow us to handle an entire program or the services specifically needed by our drug and device clients, from protocol strategy to regulatory submission. We offer flexible technological solutions to support the effective management of your trials, including the use of proprietary EDC and IVR systems, as well as providing a hosted safety surveillance platform.

Growth and Expansion

As we continue to increase our reach and provide advantages for drug and device sponsors worldwide, Synteract has expanded. In 2007, we established an office in the Research Triangle Park (RTP) area of North Carolina to better serve the East coast and to assist our global efforts. The RTP office will support clinical monitoring, site management, data management, safety surveillance, and project management as we expand these capabilities over the next several years.

Synteract currently employs over 260 professionals in its two offices and regionally throughout the U.S. Additionally, we have partnered with key international firms in order to provide outstanding patient cost and time-to-enrollment advantages in regions such as Eastern and Western Europe, Australia, India, and Brazil. Synteract endeavors to be your global outsourcing firm as we build a solid platform for quality international trials.

Our Commitment to You

We vow to continue our focus on meeting the specific needs of emerging drug, device and biotechnology firms, by providing motivated and experienced staff, customized solutions, quality deliverables, and sound regulatory compliance. In doing this, Synteract truly commits to each project, embracing our corporate philosophy of “Shared Work – Shared Vision.”